Insulin Resistance and Metabolic Syndrome

Insulin resistance lies at the core of metabolic syndrome, a cluster of metabolic abnormalities including central obesity, dyslipidemia, hypertension, and impaired glucose metabolism. Insulin resistance disrupts cellular signaling pathways, leading to metabolic dysregulation and increased cardiovascular risk. Mechanisms linking insulin resistance to metabolic syndrome involve adipose tissue dysfunction, chronic low-grade inflammation, and mitochondrial dysfunction. Lifestyle interventions targeting insulin sensitivity through dietary modifications and exercise can mitigate metabolic syndrome components and reduce cardiovascular risk. Pharmacotherapeutic approaches also aim to improve insulin sensitivity and address individual components of metabolic syndrome, emphasizing personalized management strategies in high-risk individuals.

    Related Conference of Insulin Resistance and Metabolic Syndrome

    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    August 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Insulin Resistance and Metabolic Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in